Although aberrant expression of RANKL in human salivary gland neoplasms—as modeled in our transgenic mouse—has yet to be evaluated, there is compelling support for an important role for deregulated RANKL/RANK signaling in general human oral pathobiology. This evidence concerns the gene TNFRSF11A and tumor of salivary gland.